远程患者监测赋能自动化腹膜透析与临床结局:台湾全国真实世界队列研究
该研究基于台湾全民健康保险研究数据库,比较2016-2018年启动传统APD与2020-2022年启动远程监测APD(RPM-APD)患者的结局。经逆概率加权后,RPM-APD组全因死亡和转血液透析风险更低,年住院次数更少,腹膜炎和主要不良心血管事件风险相似。
要点
- RPM-APD与全因死亡风险降低相关(HR 0.82,95%CI 0.69-0.99)
- RPM-APD与转血液透析风险降低相关(SHR 0.86,95%CI 0.77-0.96)
- RPM-APD组年住院次数显著更少(1.6 vs 2.1次,RR 0.70)
核心结论
- RPM-APD与传统APD相比,与患者生存改善、转血液透析减少和年住院次数减少相关。
研究设计与样本
- 台湾全国回顾性队列研究,使用全民健康保险研究数据库2016-2023年数据。
- 比较2016-2018年医学中心启动传统APD患者与2020-2022年启动RPM-APD患者,共2477例(RPM-APD 1258例,传统APD 1219例)。
- 采用逆概率治疗加权平衡基线协变量,平均年龄53.6岁,男性54.6%,平均随访2.0年。
主要发现
- RPM-APD组全因死亡率为4.4/100人年,传统APD组为5.3/100人年(HR 0.82,95%CI 0.69-0.99)。
- RPM-APD组转血液透析率为12.7/100人年,传统APD组为15.1/100人年(SHR 0.86,95%CI 0.77-0.96)。
- RPM-APD组年住院次数为1.6次,传统APD组为2.1次(RR 0.70,95%CI 0.68-0.73)。
- 两组腹膜炎和主要不良心血管事件风险相似。
临床怎么用
- 在当代腹膜透析照护中,RPM-APD可能有助于改善患者生存并减少转血液透析和住院。
局限性
- 回顾性队列设计可能存在残余混杂。
- 传统APD与RPM-APD的入组时间段不同,随访截止时间亦不同。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: Remote patient monitoring-enabled automated peritoneal dialysis was associated with improved survival and technique survival compared with conventional automated peritoneal dialysis. Remote patient monitoring‑enabled automated peritoneal dialysis was associated with significantly fewer annual hospitalizations compared with conventional automated peritoneal dialysis. The association between remote patient monitoring-enabled automated peritoneal dialysis and reduced hemodialysis transfer was more pronounced in younger patients and icodextrin users. INTRODUCTION: Remote patient monitoring of patients on automated peritoneal dialysis (APD) enables real-time access to treatment data and has the potential to improve clinical outcomes. However, large-scale, nationwide real-world evidence comparing RPM-enabled APD (RPM-APD) with conventional APD remains limited. METHODS: We conducted a nationwide retrospective cohort study using Taiwan's National Health Insurance Research Database between 2016 and 2023. Patients initiating APD in medical centers during 2016-2018 (conventional APD) were compared with those starting RPM-APD equipped with a remote monitoring device during 2020-2022. Baseline covariates were balanced using inverse probability of treatment weighting. The primary outcomes were all-cause death and hemodialysis transfer. Secondary outcomes included peritonitis, major adverse cardiac events, and hospitalization. Patients were followed until outcome occurrence, death, hemodialysis transfer, kidney transplantation, or the end of follow-up (December 31, 2019, for conventional APD and December 31, 2023, for RPM-APD). RESULTS: Among the 2477 patients (RPM-APD, n =1258; conventional APD, n =1219), the mean age was 53.6 years, 54.6% were male, and the mean follow-up duration was 2.0 years. After inverse probability of treatment weighting adjustment, the RPM-APD group was associated with lower risks of all-cause death (4.4 versus 5.3 events per 100 person-years; hazard ratio 0.82, 95% confidence interval [CI], 0.69 to 0.99) and hemodialysis transfer (12.7 versus 15.1 events per 100 person-years; subdistribution hazard ratio 0.86, 95% CI, 0.77 to 0.96). The risks of peritonitis and major adverse cardiac events were similar between groups, whereas patients receiving RPM-APD experienced significantly fewer annual hospitalizations (1.6 versus 2.1 times; rate ratio 0.70, 95% CI, 0.68 to 0.73). CONCLUSIONS: In this Taiwan nationwide real-world cohort study with long-term follow-up, RPM-APD was associated with improved patient survival, reduced hemodialysis transfer, and fewer annual hospitalizations compared with conventional APD. These findings support a potential role for RPM-APD in contemporary peritoneal dialysis care.
引用
- Chung MC, Yu TM, Cheng BC, et al. Remote Patient Monitoring‑Enabled Automated Peritoneal Dialysis and Clinical Outcomes: A Nationwide Real-World Cohort Study from Taiwan. Clin J Am Soc Nephrol. 2026. PMID: 42447366. doi:10.2215/CJN.0000001112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。